Advertisement

Topics

Latest "BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial" News Stories

12:27 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial" found in our extensive news archives from over 250 global news sources.

More Information about BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial for you to read. Along with our medical data and news we also list BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial Companies for you to search.

Showing "BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial" News Articles 1–25 of 29,000+

Monday 18th February 2019

Advanced Aesthetic Technologies Announces Appointment of Doug Abel As Chief Executive and President

Advanced Aesthetic Technologies, Inc. (ATT), a leader in aesthetic gel implant technology, today announced the appointment of Doug Abel as Chief Executive Officer and President, effective immediately. Mr. Abel will lead the Company’s global initiative and advance the development of its gel technology for the aesthetic and healthcare markets. Ric...


Biotech firm awarded for approach to drug development

A UK based biotech firm has been awarded a grant to develop a treatment for osteoarthritis, after promising results from a Phase I trial... The post Biotech firm awarded for approach to drug development appeared first on

FDA announces new regulatory pathway for generics

The U.S. FDA has announced new, efficient guidelines for the use of a novel pathway that provides incentives for developing generic versions of drugs that currently face little or no competition.


Pharmacy Times Continuing Education™ to Host Live Symposium on Managing Treatment Gaps with PCSK9 Inhibitors

The symposium will be held in conjunction with the Academy of Managed Care Pharmacy’s annual meeting Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will conduct a live satellite symposium titled Managing Treatment Gaps with PCSK9 Inhibitors in conjunct...

EchoNous Steps Upward with Release of Highly Reliable, All-Electronic Bladder Scanning Tool with State-of-the-Art Deep Learning Algorithm

EchoNous, an innovator focused on delivering intelligent medical tools, announces the release of EchoNous Bladder™, a highly reliable, all-electronic, non-mechanical, bladder scanning tool for nurses. To help nurses quickly determine bladder volume of patients, EchoNous Bladder combines data-rich fanning, a state-of-the-

Esserman Helps Push Breast Cancer Prevention Beyond Routine Screenings

Laura J. Esserman, MD, MBA, a 2018 Giants of Cancer Care® award winner in the Cancer Diagnostics category led the way in designing the I-SPY clinical trials, a groundbreaking effort to match patients with breast cancer to potential therapies based on molecular drivers of disease. She also has advocated for a greater understanding of the biological drivers of breast cancer, rather than relying ...

EMA implored to improve trial reporting, with over 50% of trials still missing results

The EMA needs to fix problems with the clinical trial registry to improve reporting across Europe, says TranspariMED founder, as seemingly small issues can âseriously hinder compliance.â

Alesha MacPhail murder trial: Jury told of DNA Google search – BBC News

Alesha MacPhail murder trial: Jury told of DNA Google search BBC NewsAlesha MacPhail trial UPDATES: Accused teen's phone 'used to Google "How do police find DNA"' Mirror.co.ukAlesha MacPhail: Boy accused of killing six-year-old 'told police "no comment"' Daily MailAlesha MacPhail murder trial in Glasgow hears what the accused replied when he was charged Evening TimesAlesha: Knife found on beac...

Medality Medical wins FDA IDE approval for reversal of type 2 diabetes clinical trial

Medality Medical said the device, which was designed by its founder Mark Andrew, can gently and selectively extract excess mesenteric visceral fat, which has been associated with insulin The post Medality Medical wins FDA IDE approval for reversal of type 2 diabetes clinical trial appeared first on Compelo Medical Devices.

Fresenius Kabi gets 510(k) clearance for Fenwal Amicus red blood cell exchange protocol

Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition. The Fenwal Amicus RBCx system allows for the The post Fresenius Kabi gets 510(k) clearance for Fenwal Amicus red blood cell exchange protocol appeared first on Compelo Medical Devices.

Surmodics Announces Appointment of Timothy J. Arens as Chief Financial Officer

Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced the appointment of Timothy J. Arens, Vice President of Corporate Development and Strategy, as the company’s new Chief Financial Officer (CFO), effective immediately. Arens was named inter...

Ocaliva poses enrolment obstacle in liver disease clinical trials

Ongoing and future clinical trials in second-line primary biliary cholangitis (PBC) are likely to face Intercept Pharmaceuticals’ Ocaliva (obeticholic acid)...Read More... The post Ocaliva poses enrolment obstacle in liver disease clinical trials appeared first on Pharmaceutical Technology.

Hurricanes, wildfires, power outages, and flooding all threaten manufacturing facilities and research sites. Find out how biopharma is girding for #climatechange. https://buff.ly/2EhZ31z 

Hurricanes, wildfires, power outages, and flooding all threaten manufacturing facilities and research sites. Find out how biopharma is girding for #climatechange. https://buff.ly/2EhZ31z 

Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology

The Automation of Neonatal Critical Congenital Heart Disease (CCHD) Screening Across More Than 370 Healthcare Facilities Is Expected to Improve the Process of Screening More Than 550,000 Newborns Annually by 2020 Recently at Arab Health 2019, the Saudi Arabia Ministry of Health (MOH) and Masimo (NASDAQ: MASI) jointly announced the implement...

Saama Unveils New Capabilities for Award-Winning Life Science Analytics Cloud at SCOPE

Saama Technologies, Inc., a leading data analytics company, today unveiled three new, machine learning-based capabilities that extend the existing functionality of its award-winning Life Science Analytics Cloud (LSAC). Saama announced the addition of these state-of-the-art programs infused with a

Asana BioSciences to Present Correlation Between Microbiome Changes and Clinical Efficacy With JAK/SYK Inhibitor ASN002 in the Late-Breaking News Session at the American Academy of Dermatology (AAD) Annual Congress

First demonstration of changes in Staphylococcus aureus in lesional skin, correlating with clinical efficacy Asana BioSciences, a clinical stage biopharmaceutical company, announced that it will present ASN002 data demonstrating changes in skin microbiome and correlation with clinical efficacy in patients with moderate-to-severe atopic dermat...

Astellas' Xtandi "significantly improves" progression-free survival in advanced hormone-sensitive prostate cancer

Japanese pharma firm Astellas has lifted the curtain on new data for its androgen receptor signalling inhibitor Xtandi (enzalutamide), when combined with androgen deprivation therapy (ADT), in the treatment of male patients with metastatic hormone-sensitive prostate cancer (mHSPC). It was found that the combination met its primary endpoint in Phase 3 trials, significantly reducing the risk of radi...

Rexulti falls short of goal in late-stage bipolar disorder studies

Lundbeck's Rexulti has failed to achieve the primary endpoint of two Phase III bipolar disorder studies.

Perimeter Healthcare Hires New Vice President of Clinical Services

Seasoned senior executive appointed to steer the ship of quality patient care delivery ATLANTA (PRWEB) February 18, 2019 In a bid to continually uphold its commitment to quality patient care and service delivery, Perimeter Healthcare is delighted to unveil Angela Boring as its new Vice President of Clinical Services, Quality, and Risk Management. Boring possesses a huge wealth of experience in th...

The Kroger Family of Pharmacies Partners with MarkeTouch Media to Implement Medication Synchronization Program

The Kroger Family of Pharmacies has worked with Houston-based MarkeTouch Media to apply an innovative and unique method of assisting patients through medication synchronization (“MedSync”). HOUSTON (PRWEB) February 18, 2019 The Kroger Family of Pharmacies has worked with Houston-based MarkeTouch Media to apply an innovative and unique method of assisting patients through medication synchroniz...

Exicure to Present at SMi’s RNA Therapeutics 2019 Conference

Exicure, Inc. (OTCQB:XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that its CEO, Dr. David Giljohann, will present at SMi’s RNA Therapeutics 2019 Conference being held February 20-21, 2019 at the Copthorne Tara Hotel in London, UK. Dr. Giljohann’s presentation tit...

American University of the Caribbean School of Medicine & University of Central Lancashire Launch Unique Medical Program

Global students may take U.S. medical school curriculum and obtain Doctor of Medicine (MD) degree through study in the U.K. and U.S. As many countries face a severe current and future doctor shortage, the American University of the Caribbean School of Medicine (AUC) and the University of Central Lancashire (UCLan) announced a new program aimed at helpi...

Intraoperative Parathyroid Monitoring in Hyperparathyroidism

What are the benefits of parathyroid hormone monitoring during surgery for primary hyperparathyroidism? Clinical Endocrinology

Merck Group and Pfizer announce positive results for combo therapy for RCC

Pfizer and German-based Merck Group have published promising interim results from their Phase III JAVELIN Renal 101 trial evaluating the...Read More... The post Merck Group and Pfizer announce positive results for combo therapy for RCC appeared first on Pharmaceutical Technology.

Leo Grady Joins Paige.AI as Chief Executive Officer

Seasoned Machine Learning and Medical Imaging Technology Executive Joins Paige.AI After Leading Successful Product Development Efforts at HeartFlow Paige.AI, the leading start-up focused on transforming clinical diagnosis and treatment in pathology and oncology through the use of artificial intelligence (AI), today announced that Dr. Leo Grady has ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks